ClinVar Miner

Submissions for variant NM_017780.4(CHD7):c.3202-3T>G

dbSNP: rs1060503183
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Invitae RCV000460607 SCV000552229 pathogenic CHARGE association 2016-11-30 criteria provided, single submitter clinical testing In summary, this is a rare intronic variant which has been observed de novo in affected individuals. For these reasons it has been classified as Pathogenic. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may alter RNA splicing, but this prediction has not been confirmed by published transcriptional studies. This variant has been shown to arise de novo in individuals affected with CHARGE syndrome (PMID: 22033296). Family studies have indicated that this variant was not present in the parents of this individual, which suggests that it was de novo in that affected individual (Invitae database). This variant is not present in population databases (ExAC no frequency). This sequence change falls in intron 12 of the CHD7 gene. It does not directly change the encoded amino acid sequence of the CHD7 protein.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.